Derivatives of bladder epithelial antiproliferative factor and methods of using them are disclosed. In specific embodiments, the glycopeptide compositions are useful for the treatment and/or prevention of medical conditions, including cancer. In other embodiments, there are compositions and methods related to treatment of bladder conditions. In particular embodiments, the glycopeptide comprises D-pipecolic acid or L-pipecolic acid.
申请公布号
CA2734325(A1)
申请公布日期
2010.02.25
申请号
CA20092734325
申请日期
2009.08.18
申请人
UNIVERSITY OF MARYLAND, BALTIMORE;THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMEN T OF HEALTH AND HUMAN SERVICES
发明人
KEAY, SUSAN K.;SZEKELY, ZOLTAN;KACZMAREK, PIOTR;MICHEJDA, CHRISTOPHER